BBC
BBC
About Virtus Biotech Clinical Trials ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
About Virtus Biotech Clinical Trials ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ERAS | Erasca, Inc. | 2.55% | 91.67K | $1.12M |
 ELVN | Enliven Therapeutics, Inc. | 1.82% | 19.57K | $795.60K |
 DNTH | Dianthus Therapeutics, Inc. | 1.62% | 7.83K | $711.62K |
 SYRE | Spyre Therapeutics, Inc. | 1.62% | 9.81K | $707.76K |
 TNGX | Tango Therapeutics, Inc. | 1.61% | 35.29K | $705.88K |
 RVMD | Revolution Medicines, Inc. | 1.48% | 4.18K | $646.51K |
 ORKA | Oruka Therapeutics, Inc. | 1.45% | 10.93K | $633.95K |
 DFTX | Definium Therapeutics, Inc. | 1.41% | 26.29K | $617.38K |
 LQDA | Liquidia Corporation | 1.40% | 9.89K | $613.23K |
 ALMS | Alumis Inc. Common Stock | 1.40% | 28.72K | $614.61K |
 RZLT | Rezolute, Inc. | 1.37% | 183.33K | $599.49K |
 CMPS | COMPASS Pathways plc | 1.33% | 48.96K | $583.60K |
 RLAY | Relay Therapeutics, Inc. | 1.30% | 41.09K | $571.22K |
 GHRS | GH Research PLC | 1.29% | 25.32K | $566.57K |
 ABCL | AbCellera Biologics Inc. | 1.19% | 91.16K | $522.34K |
 KOD | Kodiak Sciences Inc. | 1.14% | 13.86K | $500.62K |
 NTLA | Intellia Therapeutics, Inc. | 1.14% | 36.58K | $500.47K |
 TECX | Tectonic Therapeutic, Inc. | 1.13% | 16.70K | $497.33K |
 CNTA | Centessa Pharmaceuticals plc | 1.13% | 12.45K | $495.51K |
 ALLO | Allogene Therapeutics, Inc. | 1.12% | 218.54K | $491.71K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Netherlands
Canada
Ireland
Switzerland
Germany
SingaporeSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Netherlands Canada Ireland Switzerland Germany SingaporeHoldings (Top 20)
ERAS
Erasca, Inc.
ELVN
Enliven Therapeutics, Inc.
DNTH
Dianthus Therapeutics, Inc.
SYRE
Spyre Therapeutics, Inc.
TNGX
Tango Therapeutics, Inc.
RVMD
Revolution Medicines, Inc.
ORKA
Oruka Therapeutics, Inc.
DFTX
Definium Therapeutics, Inc.
LQDA
Liquidia Corporation
ALMS
Alumis Inc. Common Stock
RZLT
Rezolute, Inc.
CMPS
COMPASS Pathways plc
RLAY
Relay Therapeutics, Inc.
GHRS
GH Research PLC
ABCL
AbCellera Biologics Inc.
KOD
Kodiak Sciences Inc.
NTLA
Intellia Therapeutics, Inc.
TECX
Tectonic Therapeutic, Inc.
CNTA
Centessa Pharmaceuticals plc
ALLO
Allogene Therapeutics, Inc.